Health Trials

Attention-Deficit Hyperactivity Disorder(ADHD)

2

Review clinical trials related to Attention-Deficit Hyperactivity Disorder(ADHD). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Long-term Trial of EB-1020 in Pediatric Patients With ADHD

The purpose of this study is to evaluate the safety of long-term administration of mainly high doses of EB-1020 over 52 weeks in pediatric ADHD patients.

Participants needed: 180
Trial details
Phase: Phase 3Age: 6-17Biological sex: AllType: InterventionalSponsor: Otsuka Pharmaceutical Co., Ltd.Updated: Dec 23, 2025Locations: 1
Eligibility criteria

Participants who completed the 6-week treatment period and 1-week follow-up peri... [+4]

Participants who have a positive pregnancy test result at baseline. [+29]

Read more
Status: Recruiting

A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD

The purpose of this study is to evaluate the efficacy and examine the safety of two doses of EB-1020 QD XR capsule administered once daily orally in pediatric ADHD patients.

Participants needed: 315
Trial details
Phase: Phase 2, Phase 3Age: 6-17Biological sex: AllType: InterventionalSponsor: Otsuka Pharmaceutical Co., Ltd.Updated: Dec 23, 2025Locations: 1
Eligibility criteria

Participants with a primary diagnosis of ADHD based on DSM-5 diagnostic criteria... [+3]

Participants who have a positive pregnancy test result at baseline. [+24]

Read more